# Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors

> **NCT04110223** · — · UNKNOWN · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 600 (estimated)

## Conditions studied

- Radiation Toxicity
- Advanced Cancer
- Radiosensitivity

## Interventions

- **GENETIC:** next generation sequence

## Key facts

- **NCT ID:** NCT04110223
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-08
- **Primary completion:** 2021-10-08
- **Final completion:** 2021-10-08
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110223, "Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04110223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*